Skip to main content

Non-Drug Treatment of Hypertension

  • Chapter
  • 233 Accesses

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 16))

Abstract

In the past decade there has been considerable interest in treating hypertension (HBP) with non-pharmacologic methods, both old (sodium (Na+) restriction and weight reduction) and new (behavioral therapy and exercise). Yet, in its 1980 report the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure recommended some forms of non-drug therapy for HBP in some patients with little enthusiasm [1]. They felt that obese hypertensive patients should be encouraged to lose weight; that modest Na+ restriction (85 mEq/day) was a reasonably adjunctive therapy in all patients but that behavioral methods could not yet be considered a substitute for pharmacologic treatment. No recommendations were made about exercise. The rationale for non-pharmacologic treatment of HBP (Na+ restriction, weight reduction, stress reduction, and exercise) is based on experimental and epidemiologic evidence suggesting a role for excess Na+ intake, obesity, and stress in causing HBP in man.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The 1980 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 140: 1280–1284, 1980.

    Google Scholar 

  2. Freis ED: Salt, volume and the prevention of hypertension. Circulation 53: 589–595, 1976.

    PubMed  CAS  Google Scholar 

  3. Ambard L, Beujard E: Causes l’hypertension arterielle. Arch Gen Med 193: 520–533, 1904.

    Google Scholar 

  4. Allen FM, Sherrill JW: The treatment of arterial hypertension. J Metab Res 2: 429, 1922.

    Google Scholar 

  5. Kempner W: Treatment of hypertensive vascular disease with rice diet. Am J Med 4: 545–577, 1948.

    Article  PubMed  CAS  Google Scholar 

  6. Dole VP, Dahl LK, Cotzias GC, Eder HA, Krebs ME: Dietary treatment of hypertension. Clinical and metabolic studies of patients on the rice-fruit diet. J Clin Invest 29: 1189–1206, 1950.

    Article  PubMed  CAS  Google Scholar 

  7. Grollman A, Harrison TR, Mason MF, Baxter J, Crampton J, Reichsman F: Sodium restriction in the diet for hypertension. JAMA 129 (8): 533–537, 1945.

    Google Scholar 

  8. Dustan HR, Tarazi RC, Bravo EL: Diuretic and diet treatment of hypertension. Arch Intern Med 133: 1007–1013, 1974.

    Article  PubMed  CAS  Google Scholar 

  9. Parijs J, Joossens JV, Van der Linden L, Verstreken G, Amery AKPC: Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 85: 22–34, 1973.

    Article  PubMed  CAS  Google Scholar 

  10. Morgan T, Gillies A, Morgan G, Adam W, Wilson M, Carney S: Hypertension treated by salt restriction. Lancet 1: 227–230, 1978.

    Article  PubMed  CAS  Google Scholar 

  11. Heyden S, Nelius SJ, Hames CG: Obesity, salt intake, and hypertension. J Cardiovasc Med 11: 987–994, 1980.

    Google Scholar 

  12. Hunt JC, Margie JD: The influence of diet on hypertension management. Hypertension Update 4: 37–47, 1979.

    Google Scholar 

  13. Haddy FJ: Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med 69: 746–758, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Addison W: The uses of sodium chloride, potassium chloride, sodium bromide and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can Med Assoc J 18 (2): 281–285, 1928.

    PubMed  CAS  Google Scholar 

  15. McQuarrie I, Thompson WH, Anderson JA: Effects of excessive ingestion of sodium and potassium salts on carbohydrate metabolism and blood pressure in diabetic children. J Nutr 11: 77–101, 1936.

    CAS  Google Scholar 

  16. Priddle WW: Observations on the management of hypertension. Can Med Assoc J 25: 5–8, 1931.

    PubMed  CAS  Google Scholar 

  17. Meneely GR, Battarbee HD: High sodium-low potassium environment and hypertension. Am J Cardiol 38: 768–785, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Luft FC, Ranin LI, Weinberger MH: The role of potassium (K+) in the responses to extremes of sodium (Na+) intake in man. Clin Res 26 (5): 698A, 1978.

    Google Scholar 

  19. Oliver WJ, Cohen EL, Neel JV: Blood pressure, sodium intake and sodium relted hormones in the Yanomamo Indians, a ‘no-salt’ culture. Circulation 52 (1): 146–152, 1975.

    PubMed  CAS  Google Scholar 

  20. Longworth DL, Drayer JIM, Weber MA, Laragh JH: Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther 27: 544–546, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Society of Actuaries and Association of Life Insurance Medical Directors of America: Build Study 1979. Recording & Statistical Corp., USA, March 1980.

    Google Scholar 

  22. Society of Actuaries: Build and Blood Pressure Study, 1959, Vols 1 and 2, Chicago, 1959.

    Google Scholar 

  23. Stamler J: Research related to risk factors. Circulation 60: 1575–1586, 1979.

    PubMed  CAS  Google Scholar 

  24. Rabkin SW, Mathewson FAL, Hse PH: Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 39: 452–458, 1977.

    Article  PubMed  CAS  Google Scholar 

  25. Messerli FH, Christie B, DeCarvalho JGR, Aristimuno GG, Suarez DH, Dreslinski GR, Frohlich ED: Obesity and essential hypertension: Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med 141: 81–85, 1981.

    Article  PubMed  CAS  Google Scholar 

  26. Keys A, Aravanis G, Blackburn H, Van Buchen FSP, Buzino R, Djordjevic BS, Fidanza F, Karvonin JM, Menotti A, Pudda V, Taylor HL: Coronary heart disease: Overweight and obesity as risk factors. Ann Intern med 77: 15–27, 1972.

    PubMed  CAS  Google Scholar 

  27. Weinsier RL, Fuchs RJ, Kay TD, Triebwasser JH, Lancaster MC: Body fat: its relationship to coronary heart disease, blood pressure, lipids and other risk factors measured in a large male population. Am J Med 61: 815–824, 1976.

    Article  PubMed  CAS  Google Scholar 

  28. Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara P: The relation of adiposity to blood pressure and development of hypertension. The Framingham Study. Ann Intern Med 67: 48–59, 1967.

    PubMed  CAS  Google Scholar 

  29. Voors AW, Foster TA, Frerichs RR, Webber LS, Berenson GS: Studies of blood pressures in children, ages 5–14 years, in a total biracial community: the Bogalusa Heart Study. Circulation 54: 319–327, 1976.

    PubMed  CAS  Google Scholar 

  30. Rames LK, Clarke WR, Conner WE, Reiter MA, Lauer RM: Normal blood pressures and the evaluation of sustained blood pressure elevation in childhood: the Muscatine Study. Pediatrics 61: 245–251, 1978.

    PubMed  CAS  Google Scholar 

  31. Harlan WR, Cornoni-Huntley J, Leaverton PE: Blood pressure in childhood. The national health examination survey. Hypertension 1: 559–565, 1979.

    PubMed  CAS  Google Scholar 

  32. Munoz S, Munoz H, Zambrano LF: Blood pressure in a school-age population. Distribution, correlations, and prevalence of elevated values. Mayo Clin Proc 55: 623–632, 1980.

    PubMed  CAS  Google Scholar 

  33. Chiang BN, Perlman LV, Epstein FH: Overweight and hypertension. A review. Circulation 39: 403–421, 1969.

    PubMed  CAS  Google Scholar 

  34. Mann GV: The influence of obesity on health. N Engl J Med 291: 178–232, 1974.

    Article  PubMed  CAS  Google Scholar 

  35. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298: 1–6, 1978.

    Article  PubMed  CAS  Google Scholar 

  36. Dahl LK, Silver L, Christie RW: Role of salt in the fall of blood pressure accompanying reduction of obesity. N Engl J Med 258: 1186–1192, 1958.

    Article  PubMed  CAS  Google Scholar 

  37. Stamler J, Farinaro E, Mojonnier LM, Hall Y, Moss D, Stamler R: Prevention and control of hypertension by nutritional-hygienic means. JAMA 243: 1819–1823, 1980.

    Article  PubMed  CAS  Google Scholar 

  38. Stunkard A, McLaulin-Hume M: The results of the treatment for obesity. Arch Intern Med 103: 79–85, 1959.

    CAS  Google Scholar 

  39. Currey H, Malcolm R, Riddle E, Schachte M: Behavioral treatment of obesity. Limitations and results with the chronically obese. JAMA 237: 2829–2831, 1977.

    Article  PubMed  CAS  Google Scholar 

  40. Dawber TR: Risk factors in young adults: The lessons from epidemiologic studies of cardiovascular disease: Framingham, Tecumseh, and Evans County. J Am Coll Health Assoc 22: 84–95, 1973.

    PubMed  CAS  Google Scholar 

  41. Fox S, Skinner J: Physical activity and cardiovascular health. Am J Cardiol 14: 731–746, 1964.

    Article  PubMed  CAS  Google Scholar 

  42. Morris Jn, Chave SPW, Adam C, Sirey C, Epstein L, Sheehan DJ: Vigorous exercise in leisure-time and the incidence of coronary heart disease. Lancet 1: 333–339, 1973.

    Google Scholar 

  43. Paffenbarger RS, Hale WE: Work activity and coronary heart mortality. N Engl J Med 292: 545–550, 1975.

    Article  PubMed  CAS  Google Scholar 

  44. Montoye HJ, Metzner HL, Keller JB, Johnson BC, Epstein FH: Habitual physical activity and blood pressure. Med Sci Sports 4: 175–181, 1972.

    Article  PubMed  CAS  Google Scholar 

  45. Cooper KH, Pollack ML, Martin RP, White SR, Linnerud AC, Jackson A: Physical fitness levels vs selected coronary risk factors. A cross-sectional study. JAMA 236: 166–169, 1976.

    Article  PubMed  CAS  Google Scholar 

  46. Scheuer J, Tipton CM: Cardiovascular adaptations to physical training. Ann Rev Physiol 39: 221–251, 1977.

    Article  CAS  Google Scholar 

  47. Tipton CM, Matthes RD, Callahan A, Tcheng TK, Lais LT: The role of chronic exercise on resting blood pressures of normotensive and hypertensive rats. Med Sci Sports 9: 168–177, 1977.

    PubMed  CAS  Google Scholar 

  48. Evenwel R, Struyker-Boudier H: Effect of physical training on the development of hyper-tension in the spontaneously hypertensive rat. Pfluegers Arch 381: 19–24, 1979.

    Article  CAS  Google Scholar 

  49. Weiss L: Adaptive cardiovascular changes to physical training in spontaneously hypertensive and normotensive rats. Cardiovasc Res 12: 329–333, 1978.

    Article  PubMed  CAS  Google Scholar 

  50. Boyer JL, Kasch FW: Exercise therapy in hypertensive men. JAMA 211: 1668–1671, 1970.

    Article  PubMed  CAS  Google Scholar 

  51. Choquette G, Ferguson RJ: Blood pressure reduction in ‘borderline’ hypertensives following physical training. Can Med assoc J 108: 699–703, 1973.

    PubMed  CAS  Google Scholar 

  52. Wilmore JH, Royce J, Girandola RN, Katch FT, Katch VL: Physiological alterations resulting from a 10-week program of jogging. Med Sci Sports 2: 7–14, 1970.

    PubMed  CAS  Google Scholar 

  53. Frick MH, Konttinen A, Sarajas HSS: Effects of physical training on circulation at rest and during exercise. Am J Cardiol 12: 142–147, 1963.

    Article  PubMed  CAS  Google Scholar 

  54. Barry AJ, Daly JW, Pruett EDR, Steinmetz JR, Page HF, Birkhead NC, Rodahl K: The effects of physical conditioning on older individuals — I. Work capacity, circulatory-respiratory function, and work electocardiogram. J Gerontol 21: 182–191, 1966.

    PubMed  CAS  Google Scholar 

  55. Konig K: Changes in physical capacity, heart size and function in patients after myocardial infarction, who underwent a 4- to 6-week physical training program. Cardiology 62: 232–246, 1977.

    Article  PubMed  CAS  Google Scholar 

  56. Haskell WL: Cardiovascular complications during exercise training of cardiac patients. Circulation 57: 920–924, 1978.

    PubMed  CAS  Google Scholar 

  57. Gibbons LW, Cooper KH, Meyer BM, Ellison C: The acute cardiac risk of strenuous exercise. JAMA 244: 1799–1801, 1980.

    Article  PubMed  CAS  Google Scholar 

  58. Reid EL, Morgan RW: Exercise prescription: A clinical trial. Am J Public Health 69: 591–595, 1979.

    Article  PubMed  CAS  Google Scholar 

  59. Henry JP, Cassel JC: Psychosocial factors in essential hypertension. Recent epidemiologic and animal experimental evidence. Am J Epidemiol 90: 171–200, 1969.

    PubMed  CAS  Google Scholar 

  60. Buell JC, Eliot RS: The role of emotional stress in the development of heart disease. JAMA 242: 365–368, 1979.

    Article  PubMed  CAS  Google Scholar 

  61. Jenkins CD: Recent evidence supporting psychologic and social risk factors for coronary disease. N Engl J Med 294:987–994 1nd 1033–1038, 1976.

    Google Scholar 

  62. Shekelle RB: Psychosocial factors and high blood pressure. Cardiovasc Med 12: 1249 1253, 1979.

    Google Scholar 

  63. Jacobson E: Variation of blood pressure with skeletal muscle tension and relaxation. Ann Intern Med 12: 1194–1212, 1939.

    Google Scholar 

  64. Benson H: Systemic hypertension and the relaxation response. N Engl J Med 296: 1152–1156, 1977.

    Article  Google Scholar 

  65. Wallace RK, Benson H, Wilson AF: A wakeful hypometabolic physiologic state. Am J Physiol 221: 795–799, 1971.

    PubMed  CAS  Google Scholar 

  66. Benson H, Rosner BA, Marzetta BR, Klemschuk HP: Decreased blood pressure in borderline hypertensive subjects who practiced meditation. J Chron Dis 27: 163–169, 1974.

    Article  PubMed  CAS  Google Scholar 

  67. Banson H, Marzetta BR, Rosner BA, Klemschuk HM: Decreased blood pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet 1: 289–291, 1974.

    Article  Google Scholar 

  68. Blackwell B, Bloomfield S, Gartside P, Robinson A, Hanenson I, Magenheim H, Nidich S, Zigler R: Transcendental meditation in hypertension. Lancet 1: 223–226, 1976.

    Article  PubMed  CAS  Google Scholar 

  69. Stone RA, DeLeo J: Psychotherapeutic control of hypertension. N Engl J Med 294: 80–84, 1976.

    Article  PubMed  CAS  Google Scholar 

  70. Datey KK, Deshmukh SN, Dalvi CP, Vinekar SL: ‘Shavasan’: A yogic exercise in the management of hypertension. Angiology 20: 325–333, 1969.

    Article  PubMed  CAS  Google Scholar 

  71. Taylor CB, Farquhar JW, Nelson E, Agras S: Relaxation therapy and high blood pressure, Arch Gen Psychiatry 34: 339–342, 1977.

    PubMed  CAS  Google Scholar 

  72. Pollack AA, Case DB, Weber MA, Laragh JH: Limitations of transcendental meditation inthe treatment of essential hypertension. Lancet 1: 71–73, 1977.

    Article  PubMed  CAS  Google Scholar 

  73. Deabler HL, Fidel E, Dillenkoffer RL, Elder ST: The use of relaxation and hypnosis in lowering high blood pressure. Am J Clin Hypn 16: 75–83, 1973.

    Article  PubMed  CAS  Google Scholar 

  74. Patel C, North WRS: Randomised controlled trial of yoga and biofeedback in management of hypertension. Lancet 1: 93–95, 1975.

    Article  Google Scholar 

  75. Patel C: Yoga and biofeedback in the management of ‘stress’ in hypertensive patients. Clin Sci Mol Med 48: 171s–174s, 1975.

    Google Scholar 

  76. Shoemaker JE, Tasto DL: The effects of muscle relaxation on blood pressure of essential hypertensives. Behav Res Ther 13: 29–43, 1975.

    Article  PubMed  CAS  Google Scholar 

  77. Frankel BL, Patel DJ, Horwitz D, Friedewald WT, Gaarder KR: Treatment of hypertension with biofeedback and relaxation techniques. Psychosom Med 40: 276–293, 1978.

    PubMed  CAS  Google Scholar 

  78. Luthe W: Autogenic Therapy. New York: Grune & Stratton, 1969.

    Google Scholar 

  79. Roberts BW, Forester WE: Group relaxation-acute and chronic effects on essential hypertension. Cardiovasc Med 5: 575–580, 1979.

    Google Scholar 

  80. Moutsos SE, Sapira JD, Scheib ET, Shapiro AP: An analysis of the placebo effect in hospitalized hypertensive patients. Clin Pharmacol Ther 8: 676–683, 1967.

    PubMed  CAS  Google Scholar 

  81. Ayman D: An evaluation of therapeutic results in essential hypertension — I. The interpretation of symptomatic relief. JAMA 95: 246–249, 1930.

    Google Scholar 

  82. Goldring W, Chasis H, Schreiner GE, Smith HW: Reassurance in the management of benign hypertensive disease. Circulation 14: 260–264, 1956.

    PubMed  Google Scholar 

  83. Schwartz GE, Shapiro AP, Redmond DP, Ferguson DCE, Ragland DR, Weiss SM: Behavioral medicine approaches to hypertension: An integrative analysis of theory and research. J Behav Med 2: 311–363, 1979.

    Article  PubMed  CAS  Google Scholar 

  84. Shapiro D, Tursky B, Gershon E, Stern M: Effects of feedback and reinforcement on the control of human systolic blood pressure. Science 163: 588–590, 1969.

    Article  PubMed  CAS  Google Scholar 

  85. Benson H, Shapiro D, Tursky B, Schwartz GE: Decreased systolic blood pressure through operant conditioning techniques in patients with essential hypertension. Science 173: 740–742, 1971.

    Article  PubMed  CAS  Google Scholar 

  86. Kristt DA, Engel BT: Learned control of blood pressure in patients with high blood pressure. Circulation 15: 370–378, 1975.

    Google Scholar 

  87. Blanchard EB, Young LD, Haynes MR: Technique innovations. A simple feedback system for the treatment of elevated blood pressure. Behavior Ther 6: 241–245, 1975.

    Article  Google Scholar 

  88. Elder ST, Ruiz RZ, Deabler HL, Dillenkoffer RL: Instrumental conditioning of diastolic blood pressure in essential hypertensive patients. J Appl Behav Anal 6: 377–382, 1973.

    Article  PubMed  CAS  Google Scholar 

  89. Goldman H, Kleinman KM, Snow MY, Bidus DR, Korol B: Relationship between essential hypertension and cognitive functioning: Effects of biofeedback. Psychophysiology 12: 569–573, 1975.

    Article  PubMed  CAS  Google Scholar 

  90. Frankel BL, Patel D, Horwitz D, Friedwald WT, Gaarder KR: Clinical ineffectiveness of a combination of psychophysiologic therapies. Psychosom Med 39: 51–52, 1977.

    Google Scholar 

  91. Weiss T: Biofeedback training for cardiovascular dysfunctions. Med Clin North Am 61: 913–928, 1977.

    PubMed  CAS  Google Scholar 

  92. Orne MT: The efficacy of biofeedback therapy. Ann Rev Med 30: 489–503, 1979.

    Article  PubMed  CAS  Google Scholar 

  93. Schwartz GE: Voluntary control of human cardiovascular integration and differentiation through feedback and reward. Science 175: 90–93, 1972.

    Article  PubMed  CAS  Google Scholar 

  94. Shapiro AP, Schwartz GE, Ferguson DCE, Redmond DP, Weiss SM: Behavioral methods in the treatment of hypertension. A review of their clinical status. Ann Intern Med 86: 626–636, 1977.

    Google Scholar 

  95. Frumkin K, Nathan RJ, Prout MF, Cohen MC: Nonpharmacologic control of essential hypertension in man: A critical review of the experimental literature. Psychosom Med 40: 294–320, 1978.

    PubMed  CAS  Google Scholar 

  96. Reiser MF, Brust AA, Ferris EB, Shapiro AP, Harrison MB, Ransohoff W: Life situations, emotions, and the course of patients with arterial hypertension. Psychosom Med 13: 133–319, 1951.

    PubMed  CAS  Google Scholar 

  97. Shapiro AP: Consideration of multiple variables in evaluation of hypotensive drugs. JAMA 160: 30–39, 1956.

    CAS  Google Scholar 

  98. Laughlin KD, Fisher L, Sherrard DJ: Blood pressure reductions during self-recording of home blood pressure. Am Heart J 98: 629–634, 1979.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Black, H.R. (1982). Non-Drug Treatment of Hypertension. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_44

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7476-0_44

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7478-4

  • Online ISBN: 978-94-009-7476-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics